Protein-shape changes affect drug binding
Posted on: Thursday, 20 August 2009, 13:48 CDT
U.S. scientists say they have discovered protein-shape changes affect drug binding.
Computational biologists at the University of Pittsburgh School of Medicine have shown proteins have an intrinsic ability to change shape, and that allows small molecules that are attracted to a given protein to select the structure that permits the best binding.
The researchers say that premise could help in drug discovery and in designing compounds that will have the most impact on protein function to better treat a host of diseases.
Professor Ivet Bahar, who led the study, said the classical view, known as induced fit,
holds that drug binding causes a change in the target protein structure. But Bahar said it now appears a protein has many different conformations that are already available.
Gathering information about the array of conformations a target protein might exhibit can be of great use when designing new drugs, Bahar said. That allows the scientist to better identify the structural pocket into which the drug must fit to cause significant alterations in protein function, such as the inhibition of an enzyme reaction.
The research by Bahar and doctoral student Ahmet Bakan appears in the early online edition of the Proceedings of the National Academy of Sciences.
Source: United Press International
Related Articles
- Novel Polymer May Improve Protein-based Drugs
- New Australian Drug Holds Hope of Major Breakthrough in Treating Terminal Blood Cancers
- AntiCancer, Inc. Receives Patent for New Type of AIDS Drug
- Pharmaceutical and Biotechnology Companies Are Researching and Testing New Delivery Methods for Protein Drugs
- CVBT Announces Positive Pre-Clinical Results for Protein-Based Drug Candidate to Treat Osteoporosis
- Protein Drugs Tied to Formulation and Delivery Advances
- CardioVascular BioTherapeutics Co-Founder to Present Seminar on New Treatment for Heart Disease; Renowned Cardiac & Thoracic Surgeon Dr. Thomas Stegmann to Introduce Novel Protein Drug Candidate
- Scientists learn to predict protein-stabilizing ability of small molecules
- Aegis Therapeutics to Present Intravail(TM) Drug Delivery Technology at CBI's 'Protein Drugs' Conference
- More Convenient, Oral Delivery Method for Insulin, Other Protein Drugs is Described in Diabetes Technology & Therapeutics
User Comments (0)

RSS Feeds